Patent ID: 11939300
Assignee: IMMUNOMOLECULAR THERAPEUTICS, INC.
Field: Organic fine chemistry (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 2:
3. The pharmaceutical composition of claim 1, wherein:
R1 is H; C1-C4-alkyl; C3-7 cycloalkyl; or, R2 is H, C1-4 alkyl, or OR4;
R3 is H, CH3, CH2CH3, CH2CH2CH3, CH(CH3)2, CH2CH(CH3)2; C3-C6-cycloalkyl; saturated 5-6-membered heterocyclyl; or —(CH2)n—Y, where n is 1 or 2; and Y is optionally substituted phenyl; C3-C6-cycloalkyl; saturated 5-6-membered heterocyclyl; C(O)OH or C(O)(NR8)2, wherein each R8 is independently H or methyl;
R4 is H, or C1-4 alkyl;
Each R6 is independently halogen, C1-C4-alkyl, halo-C1-C4-alkyl; C1-C4-alkoxy, halo-C1-C4-alkoxy, or C3-6 cycloalkyl;
X is N or CR5, wherein R5 is H or C1-4 alkyl; and
m is 0 to 5.